Hashimoto's thyroiditis (HT)(autoimmune thyroiditis) is a clinicopathological entity
associated with chronic lymphocytic infiltration resulting in hypothyroidism. HT is a double …

Background Evidence suggests that patients with Hashimoto thyroiditis (HT) are at
significantly higher risk of developing papillary thyroid cancer (PTC). However, the course of …

Context The role of B-Raf proto-oncogene (BRAF) in papillary thyroid carcinoma (PTC) with
Hashimoto thyroiditis (HT) is unknown. Objective We aimed to explore risk factors affecting …

Simple Summary Hashimoto's thyroiditis and BRAF-mutation are protective and risk factors
for thyroid cancer aggressiveness, respectively. We assessed the influence of Hashimoto's …

Background: Papillary thyroid cancer (PTC) and lymphocytic thyroiditis (LT) co-occur with a
prevalence of about 30%. PTC harboring BRAFV600E (PTC-BRAF) confers a worse …

Background Concomitant papillary thyroid cancer (PTC) and H ashimoto's thyroiditis (HT) is
a frequent occurrence. Whether these two conditions are linked and whether PTC with …

Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …

Background: Existing evidence is controversial regarding the association between BRAF
mutation status and aggressive features of papillary thyroid cancer (PTC). Specifically, no …

Objective: To evaluate the relationship between the BRAF V600E mutation in lymph node
metastasis (LNM) and its invasive characteristics in papillary thyroid cancer (PTC). Material …

Background It has been reported that the BRAF V600E mutation is related to a low
frequency of background Hashimoto thyroiditis (HT); however, there are not many factors …